Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05778162 · ClinicalTrials.gov registry record
RISC Panel Remnant Sample Collection
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT05778162 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 1,000 participants.
The verdict
NCT05778162 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the usability and clinical utility of the Synovasure® RISC™ Panel. The secondary objective of this study is to create a repository of well-characterized synovial fluid samples from patients with knee pain and/or inflammation to be used for future research.
Interventions
- DIAGNOSTIC_TEST Synovasure® RISC™ Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2024-11-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05778162
The ClinicalTrials.gov registry entry for NCT05778162 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synovasure® RISC™ Panel is the first listed.
NCT05778162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05778162 about?
NCT05778162 is a clinical study titled "RISC Panel Remnant Sample Collection". The primary objective of this study is to evaluate the usability and clinical utility of the Synovasure® RISC™ Panel. The secondary objective of this study is to create a repository of well-characterized synovial fluid samples from patients with knee pain and/or inflammation to be used for future r...
What is the current status of trial NCT05778162?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2023-02-01. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT05778162?
The interventions under investigation include: Synovasure® RISC™ Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05778162?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.